Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia

被引:12
作者
Huang, Kuan-Po [1 ]
Chase, Andrew J. [2 ]
Cross, Nicholas C. P. [2 ]
Reiter, Andrea [3 ]
Li, Tzu-Ying [4 ,5 ]
Wang, Tso-Fu [1 ]
Chu, Sung-Chao [1 ]
Lu, Xuan-Yin [1 ]
Li, Chi-Cheng [1 ]
Kao, Ruey-Ho [1 ,6 ]
机构
[1] Buddhist Tzu Chi Gen Hosp, Div Hematol & Oncol, Hualien, Taiwan
[2] Salisbury Dist Hosp, Wessex Regional Genet Lab, Salisbury, Wilts, England
[3] Heidelberg Univ, Fak Med, D-6800 Mannheim, Germany
[4] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Cytogenet Lab, Hualien, Taiwan
[5] Tzu Chi Univ, Hualien, Taiwan
[6] Buddhist Tzu Chi Univ, Dept Oncol, Hualien, Taiwan
关键词
acute myeloid leukemia; translocation; chromosome; 8; 9;
D O I
10.1007/s12185-008-0113-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The rare recurrent translocation of (8;9)(p22;p24) with PCM1-JAK2 fusion was recently characterized in diverse hematological malignancies. Most of them are atypical chronic myeloid leukemia (CML) or other myeloproliferative disorders (MPD), and are predominantly in the male. We report a female patient with acute myeloid leukemia (AML) initially presenting with normal karyotype and negative HLA-DR expression who achieved complete remission after standard chemotherapy. The disease relapsed 7 months later with cytogenetic change of t(8;9)(p22;p24). Flow cytometry analysis showed evolutional change of immunophenotype from negative to positive HLA-DR expression and fluorescence in situ hybridization (FISH) analysis demonstrated a PCM1-JAK2 fusion gene. We speculate that the cytogenetic change of t(8;9)(p22;p24) may induce HLA-DR immunophenotypic switch and a coordination of the two evolutional changes may play a role in leukemic cell progression.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 27 条
[1]   A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma [J].
Adélaïde, J ;
Pérot, C ;
Gelsi-Boyer, V ;
Pautas, C ;
Murati, A ;
Copie-Bergman, C ;
Imbert, M ;
Chaffanet, M ;
Birnbaum, D ;
Mozziconacci, MJ .
LEUKEMIA, 2006, 20 (03) :536-537
[2]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[3]   The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene [J].
Bousquet, M ;
Quelen, C ;
De Mas, V ;
Duchayne, E ;
Roquefeuil, B ;
Delsol, G ;
Laurent, G ;
Dastugue, N ;
Brousset, P .
ONCOGENE, 2005, 24 (48) :7248-7252
[4]   Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia [J].
Dorak, MT ;
Lawson, T ;
Machulla, HKG ;
Darke, C ;
Mills, KI ;
Burnett, AK .
BLOOD, 1999, 94 (02) :694-700
[5]  
DORAK MT, 1995, LEUKEMIA, V9, P875
[6]   HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CONTAINS SEVERAL LEUKEMIA SUSCEPTIBILITY GENES [J].
DORAK, MT ;
CHALMERS, EA ;
GAFFNEY, D ;
WILSON, DWL ;
GALBRAITH, I ;
HENDERSON, N ;
WORWOOD, M ;
MILLS, KI ;
BURNETT, AK .
LEUKEMIA & LYMPHOMA, 1994, 12 (3-4) :211-222
[7]  
ESTEY E, 1995, LEUKEMIA, V9, P972
[8]  
Gilliland DG, 1998, LEUKEMIA, V12, pS7
[9]  
GUARDIOLA J, 1993, CRIT REV IMMUNOL, V13, P247
[10]   Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case [J].
Heiss, S ;
Erdel, M ;
Gunsilius, E ;
Nachbaur, D ;
Tzankov, A .
HUMAN PATHOLOGY, 2005, 36 (10) :1148-1151